Compare GLV & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GLV | OKYO |
|---|---|---|
| Founded | N/A | 2007 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.9M | 85.3M |
| IPO Year | 2004 | 2021 |
| Metric | GLV | OKYO |
|---|---|---|
| Price | $5.98 | $1.63 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.33 |
| AVG Volume (30 Days) | 30.5K | ★ 100.7K |
| Earning Date | 01-01-0001 | 07-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.88 | $1.03 |
| 52 Week High | $6.42 | $3.35 |
| Indicator | GLV | OKYO |
|---|---|---|
| Relative Strength Index (RSI) | 42.90 | 43.24 |
| Support Level | $5.84 | $1.53 |
| Resistance Level | $5.98 | $1.75 |
| Average True Range (ATR) | 0.08 | 0.12 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 45.00 | 47.14 |
Clough Global Dividend and Income Fund is a closed-ended investment management company. The fund's investment objective is to provide a high level of total return. It invests in equity and debt securities in both U.S. and non-U.S. markets of companies of any market capitalization.
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.